Key result
In 880 elderly individuals followed for 12 years, serum markers of collagen turnover (CITP and PIIINP) were significantly associated with myocardial infarction, incident heart failure, and death.
Why the study?
Do serum markers of collagen turnover (PIP, CITP, PIIINP) predict incident HF and cardiovascular outcomes in elderly individuals?
Cohort (n=880)
Do serum markers of collagen turnover (PIP, CITP, PIIINP) predict incident HF and cardiovascular outcomes in elderly individuals?
Serum markers of collagen turnover, specifically CITP and PIIINP, are significantly associated with adverse cardiac outcomes including MI, HF, and death in elderly individuals.
Answers are grounded in this paper and cite their sources.
Serum collagen markers may aid HF risk stratification in elderly adults; leaves open incremental value beyond clinical models in prospective studies.
BACKGROUND: The deposition of collagen fibrils in the myocardial extracellular matrix increases with age and plays a key role in the pathophysiology of heart failure (HF). We sought to determine the predictive value of serum markers of collagen turnover for incident HF and cardiovascular (CV) morbidity, mortality, and all-cause mortality in elderly individuals. METHODS AND RESULTS: In 880 participants in the Cardiovascular Health Study (mean age, 77±6 years; 48% women), serum levels of carboxyl-terminal peptide of procollagen type I (PIP), carboxyl-terminal telopeptide of collagen type I (CITP), and amino-terminal peptide of procollagen type III (PIIINP) were measured in 4 groups: HF with reduced ejection fraction (HFREF; n=146, EF <55%); HF with preserved EF (HFPEF; n=175, EF ≥55%), control subjects with CV risk factors but not HF (CVD; n=280), and healthy control subjects free of CV disease (n=279). Relationships between these serum markers and outcome at follow-up of 12±4 years (range, 3-17 years) was determined in six models including those adjusted for conventional risk factors, renal function, NT-proBNP and agents which interfere with collagen synthesis. For the entire cohort, in unadjusted and adjusted models, both PIIINP and CITP were associated with myocardial infarction, incident HF, hospitalization for HF, cardiovascular and all-cause mortality. In healthy control subjects, CITP and PIIINP were associated with all-cause death. In control subjects with risk factors, CITP was associated with incident HF, and in participants with HFPEF, CITP was associated with hospitalization for HF. No collagen biomarker was associated with outcome in participants with HFREF, and PIP was not associated with outcome in the cohort or its subgroups. CONCLUSIONS: In both healthy and elderly individuals with CV disease at risk of developing HF, CITP and PIIINP are significantly associated with multiple adverse cardiac outcomes including myocardial infarction, HF, and death. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00005133.
No takes yet. Share an insight, caveat, or question.
Barasch et al. (2011) conducted a cohort in Elderly individuals at risk of or with heart failure (n=880). Serum markers of collagen turnover (PIP, CITP, PIIINP) was evaluated on Incident HF, cardiovascular morbidity, mortality, and all-cause mortality. In 880 elderly individuals followed for 12 years, serum markers of collagen turnover (CITP and PIIINP) were significantly associated with myocardial infarction, incident heart failure, and death.
Synapse has enriched 10 related papers. Consider them for comparative context: